HIV and the Blood Supply - An Analysis of Crisis Decisionmaking (Paperback)

,
During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decision-making regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was done?and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area: Product treatment?Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referral?including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated blood?analyzing decisions by federal agencies and the private sector. Risk communication?examining whether infections could have been averted by better communication of the risks. Table of Contents Front Matter Executive Summary 1 Introduction 2 The U.S. Blood Supply System 3 History of the Controversy 4 Product Treatment 5 Donor Screening and Deferral 6 Regulations and Recall 7 Risk Communication to Physicians and Patients 8 Conclusions and Recommendations Appendixes A Individuals Interviewed by the Committee B Individuals Providing Oral and Written Testimony C Chronological Summary of Critical Events, NHF Communications, Knowledge Base, Risk Assessment, Clinical Options, and NHF Actions D Key Documents Provided to the Committee E Glossary of Acronyms and Terms F Committee and Staff Biographies Index

R1,926

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles19260
Mobicred@R180pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days


Toggle WishListAdd to wish list
Review this Item

Product Description

During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decision-making regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was done?and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area: Product treatment?Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referral?including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated blood?analyzing decisions by federal agencies and the private sector. Risk communication?examining whether infections could have been averted by better communication of the risks. Table of Contents Front Matter Executive Summary 1 Introduction 2 The U.S. Blood Supply System 3 History of the Controversy 4 Product Treatment 5 Donor Screening and Deferral 6 Regulations and Recall 7 Risk Communication to Physicians and Patients 8 Conclusions and Recommendations Appendixes A Individuals Interviewed by the Committee B Individuals Providing Oral and Written Testimony C Chronological Summary of Critical Events, NHF Communications, Knowledge Base, Risk Assessment, Clinical Options, and NHF Actions D Key Documents Provided to the Committee E Glossary of Acronyms and Terms F Committee and Staff Biographies Index

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

National Academies Press

Country of origin

United States

Release date

November 1995

Availability

Expected to ship within 12 - 17 working days

First published

1995

Authors

,

Editors

, ,

Dimensions

229 x 152 x 0mm (L x W x T)

Format

Paperback

Pages

352

ISBN-13

978-0-309-10375-6

Barcode

9780309103756

Categories

LSN

0-309-10375-4



Trending On Loot